Medikinet Retard, Medikinet Retard (Methylphenidate Hydrochloride)

Methylphenidate blocks the reuptake of dopamine and norepinephrine at neuronal synapses, increasing their concentrations in the central nervous system. This heightened neurotransmitter activity enhances attention, executive function, and impulse control, which are typically deficient in ADHD.

The appropriate dose of Medikinet Retard is individualized and determined by the prescribing clinician based on the patient’s age, weight, severity of symptoms, and response to therapy. Dosage adjustments are made during follow‑up visits to achieve optimal benefit while minimizing side effects.

Safety of methylphenidate during pregnancy or lactation has not been definitively established. Healthcare providers weigh potential benefits against possible risks to the fetus or infant. Pregnant or nursing individuals should discuss alternative treatment options and any concerns with their physician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and necessary import documentation.

Medikinet Retard is a long‑acting methylphenidate formulation, offering once‑daily dosing and steady plasma levels. Compared with immediate‑release methylphenidate, it provides smoother symptom control and fewer peaks and troughs. Relative to amphetamine‑based stimulants, it has a different side‑effect profile and may be preferred based on individual tolerance and comorbid conditions.

Medikinet Retard should be stored at room temperature, below 25 °C, in its original packaging. Keep the tablets away from moisture, direct sunlight, and heat sources. Do not store in the bathroom or near a kitchen sink to maintain product stability.

Medikinet Retard is taken orally, usually in the morning with or without food, as directed by the prescriber. The tablet should be swallowed whole and not crushed, chewed, or broken, to preserve its extended‑release properties and ensure consistent drug delivery.

Serious risks include cardiovascular events such as hypertension, arrhythmia, or chest pain, as well as psychiatric effects like psychosis or severe anxiety. Growth suppression in children and the potential for misuse or dependence are also important concerns that require regular monitoring by a healthcare professional.

Medikinet Retard is contraindicated in individuals with known hypersensitivity to methylphenidate or any tablet excipients, those taking monoamine oxidase inhibitors, and patients with severe cardiovascular disease, uncontrolled hypertension, or a history of psychosis. Clinicians should also avoid prescribing it to patients with a documented history of substance misuse.